CINECA IRIS Institutional Research Information System

CASSANO, GIOVANNI BATTISTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.573
AS - Asia 5.725
EU - Europa 4.772
SA - Sud America 759
AF - Africa 247
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.158
SG - Singapore 1.780
CN - Cina 1.624
IT - Italia 1.455
HK - Hong Kong 989
SE - Svezia 703
BR - Brasile 645
DE - Germania 582
BG - Bulgaria 456
VN - Vietnam 383
TR - Turchia 364
CA - Canada 341
UA - Ucraina 270
GB - Regno Unito 267
FI - Finlandia 264
FR - Francia 237
RU - Federazione Russa 203
KR - Corea 155
CH - Svizzera 141
IN - India 110
SN - Senegal 107
JP - Giappone 51
BD - Bangladesh 47
CI - Costa d'Avorio 44
IQ - Iraq 41
BE - Belgio 32
MX - Messico 30
NL - Olanda 29
SA - Arabia Saudita 28
AR - Argentina 26
GR - Grecia 26
ZA - Sudafrica 26
ES - Italia 19
PK - Pakistan 19
AT - Austria 17
AU - Australia 17
VE - Venezuela 17
EC - Ecuador 16
ID - Indonesia 16
PL - Polonia 15
CO - Colombia 14
KE - Kenya 14
EG - Egitto 13
CL - Cile 11
MA - Marocco 10
PH - Filippine 10
IR - Iran 9
JM - Giamaica 9
MY - Malesia 9
NP - Nepal 9
AZ - Azerbaigian 8
IE - Irlanda 8
UZ - Uzbekistan 8
BO - Bolivia 7
IL - Israele 7
JO - Giordania 7
OM - Oman 7
PE - Perù 7
PY - Paraguay 7
RS - Serbia 7
UY - Uruguay 7
BJ - Benin 6
KZ - Kazakistan 6
TN - Tunisia 6
DZ - Algeria 5
ET - Etiopia 5
GT - Guatemala 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
RO - Romania 5
AM - Armenia 4
BB - Barbados 4
CR - Costa Rica 4
LT - Lituania 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
NO - Norvegia 3
TH - Thailandia 3
BH - Bahrain 2
BN - Brunei Darussalam 2
GE - Georgia 2
LV - Lettonia 2
MN - Mongolia 2
PR - Porto Rico 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
Totale 26.075
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.868
Ashburn 1.363
Fairfield 1.221
Ann Arbor 1.125
Singapore 1.029
Hong Kong 971
Houston 934
Chandler 827
Santa Clara 667
Milan 650
San Jose 527
Seattle 492
Sofia 456
Cambridge 436
Dallas 431
Wilmington 430
Jacksonville 379
Shanghai 340
New York 319
Beijing 317
Ottawa 294
Izmir 274
Nanjing 196
Boardman 189
Hefei 186
Princeton 175
Lawrence 172
Medford 170
Frankfurt am Main 165
Seoul 151
Lauterbourg 148
Los Angeles 148
Bern 123
Dakar 107
Des Moines 88
Dearborn 79
Chicago 77
Nanchang 74
Hanoi 70
Ho Chi Minh City 70
Istanbul 68
Jüchen 66
Buffalo 65
Rome 64
Helsinki 58
Redondo Beach 56
Dong Ket 50
Columbus 49
London 49
The Dalles 49
Council Bluffs 48
Florence 48
San Diego 48
Serra 48
Munich 45
Abidjan 44
Falls Church 44
Tokyo 41
Redwood City 39
São Paulo 38
Washington 38
Boulder 35
Turku 32
Brussels 31
Hebei 31
Kunming 31
Bremen 30
Marseille 29
Belo Horizonte 28
Ogden 28
Norwalk 27
Tianjin 27
Shenyang 26
Lancaster 25
Phoenix 24
Denver 23
Pune 23
Changsha 22
San Francisco 22
Brooklyn 21
Hangzhou 19
Jiaxing 19
Rio de Janeiro 19
Orem 18
Zurich 18
Pisa 14
Vienna 14
Chennai 13
Da Nang 13
Dhaka 13
Fuzhou 13
Orange 13
Baghdad 12
Jeddah 12
Atlanta 11
Auburn Hills 11
Brasília 11
Curitiba 11
Lanzhou 11
Nairobi 11
Totale 19.584
Salva come PNG Salva come JPEG
Nome #
SENSITIVITY TO CHANGE AND PREDICTIVE VALIDITY OF THE MOODS-SR QUESTIONNAIRE, LAST-MONTH VERSION 453
The relationships among separation anxiety disorder, adult attachment style and agoraphobia in patients with panic disorder 310
The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder 310
[H-3]-ketanserin binding sites in different psychiatric disorders 283
Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders 273
Validity and reliability of the Structured Clinical Interview for the Trauma and Loss Spectrum (SCI-TALS). 248
Psychological and psychiatrical assessment in obese patients undergoing bariatric surgery 230
Axis I and II disorders and quality of life in bariatric surgery candidates 222
Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse 221
Development and preliminary testing of the General 5-Spectrum Measure (GSM-V) 213
VALORE PREDITTIVO DI VARIABILI PSICOPATOLOGICHE E LORO MODIFICHE DOPO DECREMENTO PONDERALE OTTENUTO MEDIANTE INTERVENTO DI BENDAGGIO GASTRICO REGOLABILE 208
Psychiatric disorders and lifetime Mood Spectrum Symptoms in Early and Late Onset Obesity 207
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders 207
CONFRONTO TRA DIVERSI STRUMENTI DI VALUTAZIONE PSICOPATOLOGICA IN PAZIENTI GRANDI OBESI CANDIDATI A CHIRURGIA BARIATRICA 204
Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders 200
Clinical correlates of depersonalization symptoms in patients with bipolar disorder 199
A multidimensional spectrum approach to post-traumatic stress disorder: comparison between the Structured Clinical Interview for Trauma and Loss Spectrum (SCI-TALS) and the Self-Report instrument (TALS-SR). 199
A spectrum model for mood disorders: a useful approach in clinical psychiatry in search of an assessment methodology 198
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia 196
Venlafaxine in somatopsychic and autopsychic depersonalization. 196
The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity 196
Catechol O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder 196
Platelet sulfotransferase in different psychiatric disorders 195
Ala147Thrsubstitution in translocator protein is associated with adult separation anxiety in patients with depression 194
Exploration of the clinical profile of rubidium chloride in depression: a systematic open trial 193
Validity and reliability of the Structured Clinical Interview for Obsessive-Compulsive Spectrum (SCI-OBS) and of the Structured Clinical Interview for Social Phobia Spectrum (SCI-SHY) 191
The Spontaneous Ala147Thr Amino Acid Substitution within the Translocator Protein Influences Pregnenolone Production in Lymphomonocytes of Healthy Individuals 191
Ligandi endogeni per i recettori delle benzodiazepine: nuovo approccio allo studio della biologia dell’ansia. 188
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression 185
Mutation analysis of oxytocin gene in individuals with adult separation anxiety 184
Psycological variables as potential predictors of successful outcomes for weight loss programs followings Swedish adjustable gastric banding 183
Predictors of response among patients with panic disorder treated with medications in a naturalistic follow-up: the role of adult separation anxiety. 183
Distinguishing affective depersonalization from anhedonia in major depression and bipolar disorder 182
Measuring Mood spectrum: comparison of interview (SCI-MOODS) and self-report (MOODS-SR)instruments 182
Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment 181
THE SPECTRUM OF SUBSTANCE USE IN MOOD AND ANXIETY DISORDERS 181
Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features. 181
The role of quetiapine in the treatment of bipolar disorder 180
Insight into illness in schizophrenia, schizoaffective disorder and mood disorders with psychotic features 180
TREATMENT EMERGENT MANIA/HYPOMANIA IN UNIPOLAR PATIENTS 178
Beyond "postpartum depressions": Specific anxiety diagnoses during pregnancy predict different outcomes Results from PND-ReScU 178
Borderline personality disorder and mood spectrum 178
Neurocognitive functioning in bulimia nervosa: the role of neuroendocrine, personality and clinical aspects 176
PRAMIPEXOLE IN TREATMENT-RESISTANT DEPRESSION: AN EXTENDED FOLLOW-UP 175
THE NEUROBIOLOGY AND CLINICAL SIGNIFICANCE OF DEPERSONALIZATION IN MOOD AND ANXIETY DISORDERS: A CRITICAL REAPPRAISAL 174
Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study 174
Comparative response to electroconvulsive therapy in medication-resistant bipolar I patietns with depression and mixed state 173
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. 170
EFFICACY AND SAFETY OF AMISULPRIDE 50 MG VERSUS PAROXETINE 20 MG IN MAJOR DEPRESSION: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY 169
Asymptomatic hypermylasemia and hyperlipasemia associated with aripiprazole 168
Oxytocin receptor polymorphisms and adult attachment style in patients with depression 167
Lifetime rhythmicity and mania as correlates of suicidal ideation and attempts in mood disorders. 167
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders 165
Citalopram in refractory obsessive-compulsive disorder: an open study 165
Prevalence and burdern of bipolar disorders in Europe 164
CATECHOL-O-METHYLTRANSFERASE GENE VARIANTS IN MOOD DISORDERS IN THE ITALIAN POPULATION 164
The factor structure of lifetime depressive spectrum in patients with unipolar depression 164
Social anxiety spectrum: Gender differences in Italian high school students 163
The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. 163
Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders 162
THE STRUCTURE OF LIFETIME MANIC-HYPOMANIC SPECTRUM 161
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder 161
The role of psychomotor activation in discriminating unipolar from bipolar disorders: a classification-tree analysis. 161
Efficacy of ECT in depression: a meta-analytic review 161
Asymptomatic hyperamylasemia and hyperlipasemia associated with aripiprazole 161
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. 160
Psychotic features in borderline patients: is there a connection to mood dysregulation? 160
THE PANIC-AGORAPHOBIC SPECTRUM: DEVELOPMENT, DESCRIPTION AND CLINICAL SIGNIFICANCE 159
Oxytocin receptor polymorphisms and adult attachment style in patients with depression 158
Intravenous citalopram in resistant OCD 157
Rating scales for the assessment of depersonalization symptoms: a review 157
PSYCOPATHOLOGICAL ASSESSMENT OF A SAMPLE OF PATIENTS CANDIDATES FOR TRANSPLANTATION 157
Social Anxiety disorder comorbidity in patients with bipolar disorder: a clinical replication 157
Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia 157
Pramipexole in treatment-resistant depression: a 16-week naturalistic study 157
Evaluation of disease awareness in a sample of patients with eating disorder: a preliminary study 155
PREVALENCE AND BURDEN OF BIPOLAR DISORDERS IN EUROPEAN COUNTRIES 155
FAMILY HISTORY OF PSYCHIATRIC DISORDERS AND ALCOHOL AND SUBSTANCE MISUSE IN PATIENTS WITH BIPOLAR I DISORDERS, SUBSTANCE USE DISORDER OR BOTH 155
AWARENESS OF DISORDER AND SUICIDE RISK IN THE TREATMENT OF SCHIZOPHRENIA: RESULTS OF THE INTERNATIONAL SUICIDE PREVENTION TRIAL 155
Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression 154
Correlation between spectrum symptomatology and personality disorders in patients affected by overweight or obesity 152
Mutation analysis of oxytocin gene in individuals with adult separation anxiety 152
LO SPETTRO ANORESSICO-BULIMICO NEI DISTURBI DELLA CONDOTTA ALIMENTARE, DELL’UMORE E NEI CONTROLLI SANI 151
HEALTH-RELATED QUALITY OF LIFE IN EUTHYMIC BIPOLAR DISORDER PATIENTS: DIFFERENCES BETWEEN BIPOLAR I AND II SUBTYPES 151
Effect of age, weight and CYP2C19 genotype on escitalopram exposure 151
internal consistency and discriminant validity of a new instrument for assessing mood symptomatology: the structured clinical interview for mood spectrum (SCI-MOODS) 151
Spettro dell'umore in gravidanza e nel postpartum 150
Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments. 150
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide 150
Axis I comorbidity in bipolar disorder with psychotic features 149
The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum. 149
Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version 148
Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder 148
MULTIDIMENSIONAL ASSESSMENT OF THE PANIC-AGORAPHOBIC SPECTRUM: RELIABILITY AND VALIDITY OF THE SPANISH VERSION OF THE PAS-SR 148
mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes., 147
The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology 147
Substance use in severe mental illness: self-medication and vulnerability factors 146
Validity and reliability of a new instrument for assessing mood symptomatology: the Structured Clinical Interview for Mood Spectrum (SCI-MOODS) 146
The Mood Spectrum Self-Report: Validation and adaptation into Spanish 145
Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report 144
Totale 18.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021181 0 0 0 0 0 0 0 0 0 0 0 181
2021/20221.862 35 100 28 126 389 261 47 99 107 77 99 494
2022/20232.328 301 225 117 227 262 274 15 171 586 13 119 18
2023/20242.045 316 281 271 161 315 330 28 42 25 56 32 188
2024/20254.922 27 184 20 255 487 477 493 307 480 667 507 1.018
2025/20264.599 337 633 435 250 456 480 755 218 182 381 434 38
Totale 26.244